Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.42 USD | +5.88% | -3.58% | -29.98% |
09-10 | Arrowhead Pharmaceuticals' Plozasiran Receives FDA Breakthrough Therapy Designation | MT |
09-10 | Arrowhead Pharmaceuticals Gets FDA Breakthrough Designation for Plozasiran | DJ |
MarketScreener is also available in this country: United States.
Switch edition